IRON CHELATION WITH ORAL DESFERRIOXAMINE

The Lancet

Volumn 316, Issue 8196, 1980, Pages 689-

  Callender, SheilaT ^a   Weatherall, D J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE;

BLOOD AND HEMOPOIETIC SYSTEM; DRUG THERAPY; HEMOCHROMATOSIS; IRON URINE LEVEL; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRELIMINARY COMMUNICATION; THERAPY;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DEFEROXAMINE; HUMAN; IRON; THALASSEMIA;

EID: 0018874982     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(80)92721-X     Document Type: Letter

References (11)

1. Treatment of primary and secondary haemochromatosis and acute iron poisoning with a new potent iron eliminating agent
2. Application of atomic absorption spectrophotometry in the determination of iron in urine
3. Intensive iron chelation therapy with desferrioxamine in iron-loading anæmias
4. Clinical and laboratory studies on the action of desferrioxamine
5. New antiarrhythmic agents: Amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocamide, verapamil
6. Aprindine
7. Aprindine: a review
8. Agranulocytosis associated with aprindine therapy
9. Aprindine (AC 1802). A new antiarrhythmic drug